Should we "bridge" anticoagulation in patients with a-fib in whom it is interrupted for a procedure?

Is a hemoglobin target of 7-9 preferable to a goal of 10-12 in critical care patients?

In patients already treated with 6-12 months of AC, does continued apixaban benefit patients?

Is edoxaban non-inferior to standard of care LMWH for treatment of VTE in cancer patients?

Should we screen patients with unexplained VTE for occult malignancies?

Does d-dimer level at the end of treatment for VTE predict recurrence?

Does hydroxyurea decrease the frequency of sickle crises in patients experiencing 3 or more per year?

Is tPA superior to heparin in treatment of submassive PE?

Review article on basics of anemia workup and management in the outpatient setting

Review article on the treatment of TTP-HUS - part of a larger series (How I treat) published in Blood which is helpful for a variety of heme diseases